Erythematous plaques with zosteriform distribution in a patient treated with TNF-α inhibitor adalimumab for psoriasis

Int J Dermatol. 2021 Nov;60(11):1366-1367. doi: 10.1111/ijd.15710. Epub 2021 Jun 17.

Authors

Cristina Garcia-Melendo¹, Xavier Cubiró¹, Carla Tubau¹, Anna Mozos², Carme Muñoz³, Lluís Puig¹

Affiliations

¹ Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
² Department of Pathology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
³ Department of Microbiology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.

PMID: 34138480
DOI: 10.1111/ijd.15710

No abstract available

MeSH terms

Adalimumab / adverse effects
Etanercept
Humans
Infliximab
Psoriasis* / drug therapy
Tumor Necrosis Factor Inhibitors
Tumor Necrosis Factor-alpha*

Substances

Tumor Necrosis Factor Inhibitors
Tumor Necrosis Factor-alpha
Infliximab
Adalimumab
Etanercept